These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30828842)

  • 1. Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomes.
    Hjellvik V; De Bruin ML; Samuelsen SO; Karlstad Ø; Andersen M; Haukka J; Vestergaard P; de Vries F; Furu K
    Stat Med; 2019 Jul; 38(15):2719-2734. PubMed ID: 30828842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data.
    Burne RM; Abrahamowicz M
    Stat Methods Med Res; 2019 Feb; 28(2):357-371. PubMed ID: 28835193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summarizing causal differences in survival curves in the presence of unmeasured confounding.
    Martínez-Camblor P; MacKenzie TA; Staiger DO; Goodney PP; O'Malley AJ
    Int J Biostat; 2020 Sep; 17(2):223-240. PubMed ID: 32946418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cautionary Note on Using Propensity Score Calibration to Control for Unmeasured Confounding Bias When the Surrogacy Assumption Is Absent.
    Wan F
    Am J Epidemiol; 2024 Feb; 193(2):360-369. PubMed ID: 37759344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods.
    Wan F; Small D; Bekelman JE; Mitra N
    Stat Med; 2015 Jun; 34(14):2235-65. PubMed ID: 25800789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.
    Stürmer T; Schneeweiss S; Avorn J; Glynn RJ
    Am J Epidemiol; 2005 Aug; 162(3):279-89. PubMed ID: 15987725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
    Stürmer T; Glynn RJ; Rothman KJ; Avorn J; Schneeweiss S
    Med Care; 2007 Oct; 45(10 Supl 2):S158-65. PubMed ID: 17909375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
    Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
    BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
    Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
    BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjustment for missing confounders in studies based on observational databases: 2-stage calibration combining propensity scores from primary and validation data.
    Lin HW; Chen YH
    Am J Epidemiol; 2014 Aug; 180(3):308-17. PubMed ID: 24966224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis.
    Burne RM; Abrahamowicz M
    Stat Med; 2016 Nov; 35(25):4588-4606. PubMed ID: 27306611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.
    Yu M; Xie D; Wang X; Weiner MG; Tannen RL
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():60-8. PubMed ID: 22552981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
    Kasza J; Wolfe R; Schuster T
    Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analysis for the effects of multiple unmeasured confounders.
    Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
    Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.
    Stürmer T; Rothman KJ; Avorn J; Glynn RJ
    Am J Epidemiol; 2010 Oct; 172(7):843-54. PubMed ID: 20716704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of propensity score calibration--a simulation study.
    Stürmer T; Schneeweiss S; Rothman KJ; Avorn J; Glynn RJ
    Am J Epidemiol; 2007 May; 165(10):1110-8. PubMed ID: 17395595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
    McCandless LC; Somers JM
    Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methods for estimating the attributable risk in the context of survival analysis.
    Gassama M; Bénichou J; Dartois L; Thiébaut AC
    BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A set of SAS macros for calculating and displaying adjusted odds ratios (with confidence intervals) for continuous covariates in logistic B-spline regression models.
    Gregory M; Ulmer H; Pfeiffer KP; Lang S; Strasak AM
    Comput Methods Programs Biomed; 2008 Oct; 92(1):109-14. PubMed ID: 18603325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.
    Karim ME; Petkau J; Gustafson P; Platt RW; Tremlett H;
    Stat Methods Med Res; 2018 Jun; 27(6):1709-1722. PubMed ID: 27659168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.